• Issue

    HIV Medicine: Volume 22, Issue 10

    e1-e3, 879-970
    November 2021
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: e1-e3
  • First Published: 20 October 2021

REVIEW ARTICLE

Free Access

Cardiac adiposity as a modulator of cardiovascular disease in HIV

Maria Bonou,  Chris J. Kapelios,  Athanase D. Protogerou,  Sophie Mavrogeni,  Constantina Aggeli,  George Markousis-Mavrogenis,  Mina Psichogiou,  John Barbetseas, 
  • Pages: 879-891
  • First Published: 12 September 2021

ORIGINAL RESEARCH

Free Access

The success of HIV combination prevention: The Dean Street model

Nicolò Girometti,  Valerie Delpech,  Sheena McCormack,  Jameel Khawam,  Sophie Nash,  Dana Ogaz,  Hamish Mohammed,  Keerti Gedela,  Diarmuid Nugent,  Sheel Patel,  Tara Suchak,  Victoria Tittle,  Alan McOwan,  Gary Whitlock, 
  • Pages: 892-897
  • First Published: 29 July 2021
Open Access

In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel

Owain Roberts,  Hannah Kinvig,  Andrew Owen,  Mohammed Lamorde,  Marco Siccardi,  Kimberly K. Scarsi, 
  • Pages: 898-906
  • First Published: 30 July 2021
Free Access

Immune reconstitution inflammatory syndrome-associated Graves disease in HIV-infected patients: clinical characteristics and response to radioactive iodine therapy

Ismaheel O. Lawal,  Akintunde T. Orunmuyi,  Gbenga O. Popoola,  Kgomotso M. G. Mokoala,  TThabo Lengana,  Mike M. Sathekge, 
  • Pages: 907-916
  • First Published: 30 July 2021
Free Access

Statin gap in patients living with HIV: assessing dose appropriateness

Kathleen J. Pincus,  Alison L. Blackman,  Samuel Y. Suen,  Sandeep Devabhakthuni,  Stormi Gale,  Zachary R. Noel,  Hyunuk Seung,  Neha Sheth Pandit, 
  • Pages: 917-923
  • First Published: 08 August 2021
Free Access

Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis

Mathieu Chalouni,  Stanislas Pol,  Philippe Sogni,  Helene Fontaine,  Karine Lacombe,  Jean-Marc Lacombe,  Laure Esterle,  Céline Dorival,  Marc Bourlière,  Firouzé Bani-Sadr,  Victor de Ledinghen,  David Zucman,  Dominique Larrey,  Dominique Salmon,  Fabrice Carrat,  Linda Wittkop, for the ANRS CO13 HEPAVIH, ANRS CO22 HEPATHER Cohorts Study Groups ,  V. Martinez, 
  • Pages: 924-935
  • First Published: 17 August 2021
Open Access

The data-collection on adverse effects of anti-HIV drugs (D:A:D) model for predicting cardiovascular events: External validation in a diverse cohort of people living with HIV

Ifedioranma Anikpo,  Afiba Manza-A. Agovi,  Matthew J. Cvitanovich,  Frank Lonergan,  Marc Johnson,  Rohit P. Ojha, 
  • Pages: 936-943
  • First Published: 19 August 2021
Open Access

Chems4EU: chemsex use and its impacts across four European countries in HIV-positive men who have sex with men attending HIV services

Gary G. Whitlock,  Konstantinos Protopapas,  Jose I. Bernardino,  Arkaitz Imaz,  Adrian Curran,  Christof Stingone,  Sivapatham Shivasankar,  Sarah Edwards,  Sophie Herbert,  Konstantinos Thomas,  Rafael Mican,  Paula Prieto,  Jorge Nestor Garcia,  Massimo Andreoni,  Samantha Hill,  Hajra Okhai,  David Stuart,  Adam Bourne,  Katie Conway, 
  • Pages: 944-957
  • First Published: 25 August 2021

SHORT COMMUNICATIONS

Free Access

Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance

Pierre Frange,  Stephane Blanche,  Florence Veber,  Veronique Avettand-Fenoel, 
  • Pages: 958-964
  • First Published: 08 August 2021
Free Access

Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs

Ceilidh Grimshaw,  Lynsey Boyd,  Matt Smith,  Claudia S. Estcourt,  Rebecca Metcalfe, 
  • Pages: 965-970
  • First Published: 28 September 2021